Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice

International Immunology

Volumn 21, Issue 5, 2009, Pages 511-522

  Boldizsar, Ferenc ^a,b   Tarjanyi, Oktavia ^a   Nemeth, Peter ^b   Mikecz, Katalin ^a   Glant, Tibor T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cytokines; Peritoneum; Rheumatoid arthritis; Spleen; T cells

Indexed keywords

AGGRECAN; GAMMA INTERFERON; INTERLEUKIN 17; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE PREDISPOSITION; EFFECTOR CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PERITONEUM CELL; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; ANIMAL; ARTHRITIS; BAGG ALBINO MOUSE; DBA MOUSE; FEMALE; HELPER CELL; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PERITONEUM; PERITONEUM LAVAGE; T LYMPHOCYTE SUBPOPULATION;

AGGRECANS; ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL POLARITY; FEMALE; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, SCID; PERITONEAL LAVAGE; PERITONEUM; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 65549089043     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp018     Document Type: Article

References (52)

1. Glant, T. T., Mikecz, K., Arzoumanian, A. and Poole, A. R. 1987. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum. 30:201.
2. Glant, T. T., Finnegan, A. and Mikecz, K. 2003. Proteoglycan-induced arthritis: Immune regulation, cellular mechanisms and genetics. Crit. Rev. Immunol. 23:199.
3. Buzas, E., Vegvari, A., Murad, Y. M., Finnegan, A., Mikecz, K. and Glant, T. T. 2005. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis. Cell. Immunol. 235:98.
4. Glant, T. T., Buzas, E. I., Finnegan, A., Negroiu, G., Cs-Szabó, G. and Mikecz, K. 1998. Critical role of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J. Immunol. 160:3812.
5. Mikecz, K., Glant, T. T., Buzás, E. and Poole, A. R. 1990. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum. 33:866.
6. Broche, F. and Tellado, J. M. 2001. Defense mechanisms of the peritoneal cavity. Curr. Opin. Crit. Care 7:105.
7. Krist, L. F., Eestermans, I. L., Steenbergen, J. J. et al. 1995. Cellular composition of milky spots in the human greater omentum: An immunochemical and ultrastructural study. Anat. Rec. 241:163.
8. Fagarasan, S., Watanabe, N. and Honjo, T. 2000. Generation, expansion, migration and activation of mouse B1 cells. Immunol. Rev. 176:205.
9. Boes, M. 2000. Role of natural and immune IgM antibodies in immune responses. Mol. Immunol. 37:1141.
10. Vigna, A. F., Godoy, L. C., Rogerio de Almeida, S., Mariano, M. and Lopes, J. D. 2002. Characterization of B-1b cells as antigen presenting cells in the immune response to gp43 from Paracoccidioides brasiliensis in vitro. Immunol. Lett. 83:61.
11. Zhong, X., Gao, W., Degauque, N. et al. 2007. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur. J. Immunol. 37:2400.
12. Kantor, A. B., Stall, A. M., Adams, S., Herzenberg, L. A. and Herzenberg, L. A. 1992. Differential development of progenitor activity for three B-cell lineages. Proc. Natl Acad. Sci. USA 89:3320.
13. Billiau, A. and Matthys, P. 2001. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J. Leukoc. Biol. 70:849.
14. Hanyecz, A., Berlo, S. E., Szanto, S., Broeren, C. P. M., Mikecz, K. and Glant, T. T. 2004. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype. Arthritis Rheum. 50:1665.
15. Grun, J. L. and Maurer, P. H. 1989. Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous interleukin 1 in proliferative responses. Cell. Immunol. 121:134.
16. Kool, M., Soullie, T., van Nimwegen, M. et al. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205:869.
17. Gordon, W. C., Prager, M. D. and Carroll, M. C. 1980. The enhancement of humoral and cellular immune responses by dimethyldioctadecylammonium bromide. Cell. Immunol. 49:329.
18. Mikecz, K., Glant, T. T. and Poole, A. R. 1987. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum. 30:306.
19. Otto, J. M., Cs-Szabó, G., Gallagher, J. et al. 1999. Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis. Arthritis Rheum. 42:2524.
20. Bardos, T., Mikecz, K., Finnegan, A., Zhang, J. and Glant, T. T. 2002. T and B cell recovery in arthritis adoptively transferred to SCID mice: antigen-specific activation is required for restoration of autopathogenic CD4+ Th1 cells in a syngeneic system. J. Immunol. 168:6013.
21. Finnegan, A., Mikecz, K., Tao, P. and Glant, T. T. 1999. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J. Immunol. 163:5383.
22. Holló, K., Glant, T. T., Garzó, M., Finnegan, A., Mikecz, K. and Buzas, E. I. 2000. Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis. Clin. Exp. Immunol. 120:167.
23. Cao, Y., Brombacher, F., Tunyogi-Csapo, M., Glant, T. T. and Finnegan, A. 2007. Interleukin-4 regulates proteoglycan-induced arthritis by specifically suppressing the innate immune response. Arthritis Rheum. 56:861.
24. Glant, T. T. and Mikecz, K. 2004. Proteoglycan aggrecan-induced arthritis. A murine autoimmune model of rheumatoid arthritis. Methods Mol. Med. 102:313.
25. Wells, S. M., Kantor, A. B. and Stall, A. M. 1994. CD43 (S7) expression identifies peripheral B cell subsets. J. Immunol. 153:5503.
26. Berlo, S. E., Guichelaar, T., ten Brink, C. B. et al. 2006. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice. Arthritis Rheum. 54:2423.
27. Shibuya, K., Robinson, D., Zonin, F. et al. 1998. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J. Immunol. 160:1708.
28. Zhang, J., Bardos, T., Shao, Q. et al. 2003. IL-4 potentiates activated T cell apoptosis via an IL-2-dependent mechanism. J. Immunol. 170:3495.
29. Colgan, J. and Rothman, P. 2006. All in the family: IL-27 suppression of T(H)-17 cells. Nat. Immunol. 7:899.
30. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910.
31. Nakae, S., Nambu, A., Sudo, K. and Iwakura, Y. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171:6173.
32. Doodes, P. D., Cao, Y., Hamel, K. et al. 2008. Development of proteoglycan-induced arthritis is independent of IL-17. J. Immunol. 181:329.
33. Kotake, S., Udagawa, N., Takahashi, N. et al. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103:1345.
34. Ziolkowska, M., Koc, A., Luszczykiewicz, G. et al. 2000. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164:2832.
35. Lubberts, E., Joosten, L. A., Oppers, B. et al. 2001. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 167:1004.
36. Sakaguchi, N., Takahashi, T., Hata, H. et al. 2003. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426:454.
37. Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S. and Iwakura, Y. 2003. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl Acad. Sci. USA 100:5986.
38. Komiyama, Y., Nakae, S., Matsuki, T. et al. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177:566.
39. Tunyogi-Csapo, M., Kis-Toth, K., Radacs, M. et al. 2008. Cytokinecontrolled RANKL and osteoprotegerin expression by human an mouse synovial fibroblasts: Fibroblast-mediated pathologic bone resorption. Arthritis Rheum, 58:2397.
40. Chesnut, R. W. and Grey, H. M. 1986. Antigen presentation by B cells and its significance in T-B interactions. Adv. Immunol. 39:51.
41. O'Neill, S. K., Shlomchik, M. J., Glant, T. T., Cao, Y., Doodes, P. D. and Finnegan, A. 2005. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J. Immunol. 174:3781.
42. Duncan, D. D. and Swain, S. L. 1994. Role of antigen-presenting cells in the polarized development of helper T cell subsets: Evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Eur. J. Immunol. 24:2506.
43. Stoop, R., Gal, I., Glant, T. T., McNeish, J. D. and Mikecz, K. 2002. Trafficking of CD44-deficient murine lymphocytes under normal and inflammatory conditions. Eur. J. Immunol. 32:2532.
44. Youinou, P. and Renaudineau, Y. 2007. The paradox of CD5-expressing B cells in systemic lupus erythematosus. Autoimmun. Rev. 7:149.
45. Youinou, P., Hillion, S., Jamin, C., Pers, J. O., Saraux, A. and Renaudineau, Y. 2006. B lymphocytes on the front line of autoimmunity. Autoimmun. Rev. 5:215.
46. Katz, D., Lehrer, S., Galan, O., Lachmi, B. E. and Cohen, S. 1991. Adjuvant effects of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and aluminium hydroxide on neutralizing antibody, antibody-isotype and delayed-type hypersensitivity responses to Semliki Forest virus in mice. FEMS Microbiol. Immunol. 3:305.
47. Klinguer-Hamour, C., Libon, C., Plotnicky-Gilquin, H. et al. 2002. DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine. Vaccine 20:2743.
48. Snippe, H., Johannesen, L., Lizzio, E. and Merchant, B. 1980. Variable expression of delayed hypersensitivity in different mouse strains using dimethyl dioctadecyl ammonium bromide as an adjuvant. Immunology 39:399.
49. Fischer, M. and Ehlers, M. 2008. Toll-like receptors in autoimmunity. Ann. N. Y. Acad. Sci. 1143:21.
50. Marsland, B. J. and Kopf, M. 2007. Toll-like receptors: Paving the path to T cell-driven autoimmunity? Curr. Opin. Immunol. 19:611.
51. Subudhi, S. K., Alegre, M. L. and Fu, Y. X. 2005. The balance of immune responses: Costimulation verse coinhibition. J. Mol. Med. 83:193.
52. Adarichev, V. A., Vermes, C., Hanyecz, A. et al. 2006. Antigen-induced differential gene expression in lymphocytes and gene expression profile in synovium prior to the onset of arthritis. Autoimmunity 39:663.